Compare Star Bulk Carriers Corp (SBLK) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Star Bulk Carriers Corp vs BIO-TECHNE Corp — how do they compare? Star Bulk Carriers Corp trades at $30.47 (market cap $3.45B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: BIO-TECHNE Corp is far larger — about 3.3× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.33%). Which is the better fit depends on your goals — on Pluang, investors hold Star Bulk Carriers Corp for 24 Days and BIO-TECHNE Corp for 63 Days on average.
| SBLK | TECH | |
|---|---|---|
Market Cap | $3.45B | $11.37B |
Volume | 1,355,871 | 3,153,511 |
Sector | Industrials | Health |
52-Week High | $32.49 | $72.61 |
52-Week Low | $16.79 | $43.31 |
Typical Hold Time | 24 Days | 63 Days |
Enterprise Value | $4.13B | $11.40B |
Dividend Yield | 6.33% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Star Bulk Carriers (SBLK) trades at $29.69, down 0.57% on the day, with a bearish technical signal from moving averages but neutral oscillators. Fundamentally, the company shows strong profitability with a 23.87% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights insider buying and a declared $0.90 dividend for H2 2026, reflecting management confidence.
The outlook is positive given robust earnings performance and attractive valuation multiples, though near-term technical weakness and reliance on shipping market cycles pose risks. Analyst consensus is bullish with 14 buy ratings, supporting potential upside if operational strength continues.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
